<DOC>
	<DOCNO>NCT01354275</DOCNO>
	<brief_summary>Outcomes IVF/ICSI cycle woman PCOS undergo Gonadotropin Releasing Hormone ( GnRH ) agonist GnRH Antagonist fix protocol .</brief_summary>
	<brief_title>In Vitro Fertilization Outcomes Two Treatment Protocols Women With Polycystic Ovary Syndrome</brief_title>
	<detailed_description>Women PCOS undergo IVF/ICSI cycle evaluate two different protocol . One arm study include oral contraceptive plus GnRH agonist protocol 150 IU FSH ( standard dose ) second arm include oral contraceptive plus GnRH Antagonist 150 IU FSH dose fixed 6th day start GnRH Antagonist .</detailed_description>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Prolactin Release-Inhibiting Factors</mesh_term>
	<criteria>PCOS woman undergo ICSI cycle All woman administer 150 IU rec FSH Women endocrinopathies woman old 35 third IVF/ICSI cycle previous current use metformin</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>PCOS</keyword>
	<keyword>IVF/ICSI</keyword>
	<keyword>Clinical Pregnancy rate</keyword>
	<keyword>GnRH Antagonist</keyword>
	<keyword>GnRH Agonist</keyword>
</DOC>